Machine signal
Active cluster sell — 7 distinct insiders, $104.8M, window ends Nov 11, 2026.
Figures computed from official regulatory filings — .
Analysttarget 410.26 USD (+50%) · consensus 4.64/5 · 20 buy · 2 hold · 0 sell
Ownershipinsiders 2.96% · institutions 101.44% · short 4.3% of float · 3.74d to cover
In USD · as of Nov 16, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Natera, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
Market information source · Nov 16, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Nov 16, 2026
Purchases and sales · full history
15 buys1,953 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Sheena Jonathan | Sell | $13K | SEC | ||
| Sheena Jonathan | Sell | $46.1K | SEC | ||
| Sheena Jonathan | Sell | $15.2K | SEC | ||
| Sheena Jonathan | Sell | $12.9K | SEC | ||
| Sheena Jonathan | Sell | $57.9K | SEC | ||
| Sheena Jonathan | Sell | $12.6K | SEC | ||
| Sheena Jonathan | Sell | $26.9K | SEC | ||
| Sheena Jonathan | Sell | $12.9K | SEC | ||
| Sheena Jonathan | Sell | $38.4K | SEC | ||
| Sheena Jonathan | Sell | $12.6K | SEC | ||
| Sheena Jonathan | Sell | $76.6K | SEC | ||
| Sheena Jonathan | Sell | $51.2K | SEC | ||
| Sheena Jonathan | Sell | $25.8K | SEC | ||
| Sheena Jonathan | Sell | $76.7K | SEC | ||
| Sheena Jonathan | Sell | $23.2K | SEC | ||
| Sheena Jonathan | Sell | $53.3K | SEC | ||
| Sheena Jonathan | Sell | $33.5K | SEC | ||
| Sheena Jonathan | Sell | $13K | SEC | ||
| Sheena Jonathan | Sell | $4.6K | SEC | ||
| Sheena Jonathan | Sell | $34.1K | SEC | ||
| Sheena Jonathan | Sell | $15.4K | SEC | ||
| Sheena Jonathan | Sell | $14.6K | SEC | ||
| Sheena Jonathan | Sell | $33.1K | SEC | ||
| Sheena Jonathan | Sell | $6.4K | SEC | ||
| Sheena Jonathan | Sell | $41.9K | SEC |